Grifols, S.A.

Healthcare

NASDAQ:GRFS · NASDAQ Global Select

Market Cap $6.46B Beta 1.17 P/E (TTM) 14.8

$7.64 +2.00%

+$0.15 today

52W Low $7.26High $11.14

Vol 0.45M · Avg 0.72M

EPS (TTM)$0.61

Div Yield1.66%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-12.69%

Period High

$10.74

Period Low

$7.32

Latest

$7.64

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.40B

Globus Medical, Inc.

NYSE:GMED

$10.84B

Molina Healthcare, Inc.

NYSE:MOH

$10.43B

Masimo Corporation

NASDAQ:MASI

$9.42B

Henry Schein, Inc.

NASDAQ:HSIC

$9.26B

Corcept Therapeutics Incorporated

NASDAQ:CORT

$8.90B

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$8.24B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.73B

AptarGroup, Inc.

NYSE:ATR

$7.51B

Avantor, Inc.

NYSE:AVTR

$6.41B

What is the latest GRFS filing?

The latest filing shown is 6-K dated May 15, 2026.

How many recent filings does GRFS have?

Intrinsic Alpha currently shows 20 recent filings for GRFS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.